Highlights
- Today’s Research Article: PRP Outperforms Steroids in Joint Healing — MRI-Proven.
- Questions from the Field: PRP = Fewer Replacements, Longer Relief — Even Years Later.
- Let’s Get Down to Business: Boost Practice Revenue with Cash-Based Services Patients Want.
- Come Join Us: Learn, Network, and Level Up — See You in Vegas!
If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.
Today’s Research Article
The role of intra-articular injection of autologous platelet-rich plasma versus corticosteroids in the treatment of synovitis in lumbar facet joint disease
Shahdan Y. Kotb, MD, Nahed M. Sherif, MD, PhD, Hala A. Saleh, MD, PhD, Sahar F. Ahmed, MD, PhD, Hossam M. Sakr, MD, PhD, Mohamed O. Taeimah, MD, PhD.
Summary:
This randomized, single-blinded study from Cairo compared the effectiveness of platelet-rich plasma (PRP) versus corticosteroids (CS) in treating lumbar facet joint (FJ) synovitis in 30 patients with chronic low back pain. Both treatments resulted in significant improvements in pain, function, range of motion, and MRI-detected inflammation at 3-month follow-up. However, PRP showed greater overall reduction in synovitis severity across all lumbar levels, suggesting stronger biological healing effects.
While both groups experienced pain relief and functional gains, PRP provided more widespread and consistent improvements in MRI-confirmed inflammation. The study supports PRP as a potentially superior option, particularly for patients seeking longer-lasting, regenerative benefits without the side effects associated with corticosteroids.
Doctor-to-Patient Talking Points on Why to Choose PRP (Based on the Study):
